Author

Hongmei Xu

h-index 4 View on Semantic Scholar

We have 1 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

LINC01929 promotes breast cancer progression through a TFRC-associated ferroptosis pathway.

It is suggested that targeting LINC01929 to regulate TFRC-mediated ferroptosis could represent a promising therapeutic strategy for BC, positioning both LINC01929 and TFRC as potential biomarkers and therapeutic targets.

Gang Li, Zhijun Yu, Hongmei Xu et al. · Cell Death Discovery · 0 citations